Mode
Text Size
Log in / Sign up
N/A Completed N=64 Randomized Double-blind Treatment

A Two-Week Crossover Dispensing Evaluation Of Orion Daily Wear Soft Contact Lens

Source: ClinicalTrials.gov NCT04585646 ↗
Enrolled (actual)
64
Serious AEs
0.0%
Results posted
May 2022
Primary outcomePrimary: Subjective Response for Vision Satisfaction — 24; 28; 30; 24 Participants

Summary

The primary objective of the study is to evaluate the clinical performance of test lens (Orion) in comparison with control lens (Gemini) over a period of two weeks of wear.

Outcome Measures

OutcomeResultp-value
PRIMARY
Subjective Response for Vision Satisfaction
24; 28; 30; 24; 4; 7
PRIMARY
Subjective Response for Overall Vision Satisfaction
42; 34; 41; 48; 8; 10
PRIMARY
Subjective Response for Overall Vision Quality
87; 88
SECONDARY
Subjective Overall Comfort Satisfaction
22; 17; 25; 19; 6; 14
SECONDARY
Subjective Preference for Comfort
13; 21; 10; 7; 8
SECONDARY
Lens Surface Wettability Performance
3.31; 3.40
SECONDARY
Horizontal Lens Centration
-0.13; -0.17
SECONDARY
Vertical Lens Centration
0.09; 0.12
SECONDARY
Post-blink Movement
0.29; 0.32
SECONDARY
Lens Horizontal Mobility Rating
2.36; 2.41
SECONDARY
Corneal Staining Extent
0.00; 0.00; 0.02; 0.01; 0.00; 0.00
SECONDARY
Overall Lens Fit Acceptance
3.22; 3.11
SECONDARY
Lens Handling Satisfaction
27; 14; 20; 27; 8; 11
SECONDARY
Subjective Overall Lens Handling
87; 83

Eligibility Criteria

Inclusion Criteria

  • Is at least 18 years of age and has full legal capacity to volunteer.
  • Is no greater than 55 years of age.
  • Has read and understood the information consent letter.
  • Is willing and able to follow instructions and maintain the appointment schedule.
  • Is an adapted soft contact lens wearer having worn lenses for a minimum of 4 weeks prior to the study.
  • Has spectacle cylinder ≤1.00D in both eyes.
  • Has spherical contact lens power requirement between -1.00D and -6.00D in both eyes.
  • Has manifest refraction visual acuities (VA) equal to or better than logMAR equivalent of 20/20 in each eye.
  • Wears CLs in both eyes (monovision acceptable, but not monofit)
  • Has clear corneas and no active ocular disease.
  • Has not worn lenses for at least 12 hours before the examination.
  • Is willing to wear the study contact lenses for a minimum 8 hours per day/6 days per week

Exclusion Criteria

  • Has never worn contact lenses before.
  • Has any systemic disease affecting ocular health.
  • Is using any systemic or topical medications that will affect ocular health.
  • Has any ocular pathology or severe insufficiency of lacrimal secretion (moderate to severe dry eyes) that would affect the wearing of contact lenses.
  • Has persistent, clinically significant corneal or conjunctival staining using sodium fluorescein dye.
  • Has any clinically significant lid or conjunctival abnormalities, active neovascularization or any central corneal scars.
  • Is aphakic.
  • Has strabismus/amblyopia.
  • Has undergone corneal refractive surgery.
  • Is pregnant, lactating or planning a pregnancy.
  • Is participating in any concurrent clinical or research study.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04585646). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search